ascopubs.org

Small molecule pan-bcl-2 inhibitor AT-101 induces apoptosis in NSCLC by up-regulating noxa and enhances antitumor activity of docetaxel or targeted kinase inhibitors

Single nucleotide polymorphisms of TSER, ATM, RecQ1 genes association with survival in pancrease cancer This is an ASCO Meeting Abstract from the 2009 ASCO Annual Meeting I. This abstract does not ...
ascopubs.org

Mebendazole induces apoptosis in distinct melanoma subtypes via Bcl-2 dependent mechanism

Prognostic impact of baseline LDH on survival independent of tumor burden in advanced melanoma: Results of phase III trial of oblimersen-dacarbazine (OBL-DTIC) vs DTIC No significant financial ...
BioWorld

Chinese researchers discover new apoptosis regulator Bcl-2 inhibitors

Biopolar Hongye (Nantong) Pharmaceutical Co. Ltd. and Hangzhou Hertz Pharmaceutical Co. Ltd. have described apoptosis regulator Bcl-2 wild-type, Bcl-2 (D103Y mutant) and/or Bcl-2 (G101V mutant) ...
PR Newswire

BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | DelveInsight

The growth of the BCL-2 inhibitors market is expected to be driven primarily by rising incidence, increased awareness and access to treatment, and the launch of emerging drugs such as Lisaftoclax ...